Evidence map›Paper›PMID 36780242›Full record

ArticleESCAPE. European Symposium on Computer Aided Process Engineering2022

Development of mechanistic reduced order models (ROMs)for glidant and lubricant effects in continuous manufacturing of pharmaceutical solid-dosage forms.

Sunidhi Bachawala, Marcial Gonzalez

Abstract read
In one paragraph

Article in ESCAPE. European Symposium on Computer Aided Process Engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sunidhi BachawalaSchool of Mechanical Engineering, Purdue University, West Lafayette, IN 47907, USA.
Marcial GonzalezSchool of Mechanical Engineering, Purdue University, West Lafayette, IN 47907, USA.

Funding

Industry 4.0 Implementation in Continuous Pharmaceutical ManufacturingU01FD006487 · FDA · UNIVERSITY OF DELAWARE · PI IERAPETRITOU, MARIANTHI · 2018 to 2020
$4.0M
FDA HHS U01 FD006487
6 · The paper itself

Abstract

As the pharmaceutical industry transitions from batch to continuous manufacturing, real-time monitoring, and mechanistic model-based control are essential to conform to FDA quality standards. Glidants and lubricants are known to affect the Critical Quality Attributes (CQAs) of a tablet such as tensile strength, tablet porosity, and dissolution profile (Razavi et al., 2018; Apeji and Olowosulu, 2020). Quantitative models for predicting these effects are essential for enabling centralized control strategies of lubricant and glidant feeding and blending in direct compression tableting lines. This work presents the development of mechanistic reduced order models to capture the effects of lubricant (magnesium stearate) and glidant (silica) on CQAs and Critical Process Parameters (CPPs). A Latin Hypercube experimental campaign with thirty different mixing conditions of silica with MCC (Avicel PH200) and APAP (Acetaminophen) was carried out using a Natoli NP400 tablet press and a SOTAX AT4 tablet tester. Experiments show that the tensile strength and blend bulk density are significantly affected by the mixing conditions of silica. Similarly, adding magnesium stearate (MgSt) changes the bulk density of the blend, compaction force required to form a tablet, and tensile strength of the tablet, depending on the lubrication conditions (Mehrotra et al., 2007; Razavi et al., 2018).

Indexed as

continuous pharmaceutical manufacturingglidant effectsLubricant effects

Identifiers

PMID36780242
PMCPMC9912103

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.